Healthequity Inc (HQY) stock expected to gain 19.21% in the coming months

At the time of writing, Healthequity Inc [HQY] stock is trading at $80.98, up 1.53%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HQY shares have gain 10.36% over the last week, with a monthly amount drifted -2.21%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Healthequity Inc [NASDAQ: HQY] stock has seen the most recent analyst activity on April 04, 2024, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $101. Previously, JP Morgan reaffirmed its Overweight rating on April 02, 2024, and elevated its price target to $108. On January 03, 2024, Barclays initiated with a Overweight rating and assigned a price target of $84 on the stock. Robert W. Baird upgraded its rating to a Outperform and increased its price target to $87 on September 21, 2023. Goldman upgraded its rating to a Neutral and raised its price target to $77 on October 21, 2022. KeyBanc Capital Markets started tracking with a Overweight rating for this stock on September 16, 2022, and assigned it a price target of $85. In a note dated July 12, 2022, Goldman initiated an Sell rating and provided a target price of $59 on this stock.

For the past year, the stock price of Healthequity Inc fluctuated between $61.50 and $88.26. Currently, Wall Street analysts expect the stock to reach $96.54 within the next 12 months. Healthequity Inc [NASDAQ: HQY] shares were valued at $80.98 at the most recent close of the market. An investor can expect a potential return of 19.21% based on the average HQY price forecast.

Analyzing the HQY fundamentals

According to Healthequity Inc [NASDAQ:HQY], the company’s sales were 1.04B for trailing twelve months, which represents an 17.66% jump. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.09%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.04 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.45.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 79.86 points at the first support level, and at 78.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 82.24, and for the 2nd resistance point, it is at 83.50.

Ratios To Look Out For

It is important to note that Healthequity Inc [NASDAQ:HQY] has a current ratio of 4.39. In addition, the Quick Ratio stands at 4.39 and the Cash Ratio stands at 2.72. Considering the valuation of this stock, the price to sales ratio is 6.76, the price to book ratio is 3.36 and price to earnings (TTM) ratio is 88.15.

Transactions by insiders

Recent insider trading involved Wellborn Gayle Furgurson, Director, that happened on Jul 09 ’24 when 5297.0 shares were sold. Former Director, Corvino Frank completed a deal on Jul 08 ’24 to sell 7705.0 shares. Meanwhile, PRESIDENT AND CEO Kessler Jon sold 6675.0 shares on Jun 25 ’24.

Related Posts